gip 1 vs glp 1 Comparison between GLP-1 RA and the GLP-1/GIP dual agonist GLP-1 and GIP in Type

23 Adiposity Obesity is associated with low-grade chronic inflammation

Common side effects include nausea, diarrhea, constipation, and vomiting

Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L

"But the data's been there the whole time" to show that's not necessarily the case, Cree adds

If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated Hypoglycemia: Adult patients with type 2 diabetes on an insulin secretagogue (eg, a sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia with use of Saxenda

Additionally, the peptide has been studied in animal models for its ability to stimulate growth hormone release while maintaining relatively selective endocrine effects compared to other secretagogues